PuraPharm (HKSE:01498) Price-to-Operating-Cash-Flow : 1.81 (As of Jul. 09, 2025)

View and export this data going back to 2015. Start your Free Trial

What is PuraPharm Price-to-Operating-Cash-Flow?

As of today (2025-07-09), PuraPharm's share price is HK$0.475. PuraPharm's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.26. Hence, PuraPharm's Price-to-Operating-Cash-Flow Ratio for today is 1.81.

The historical rank and industry rank for PuraPharm's Price-to-Operating-Cash-Flow or its related term are showing as below:

HKSE:01498' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0.06 Med: 2.78 Max: 8.31
Current: 1.81

During the past 11 years, PuraPharm's highest Price-to-Operating-Cash-Flow Ratio was 8.31. The lowest was 0.06. And the median was 2.78.

HKSE:01498's Price-to-Operating-Cash-Flow is ranked better than
97.66% of 684 companies
in the Drug Manufacturers industry
Industry Median: 18.28 vs HKSE:01498: 1.81

PuraPharm's Cash Flow from Operations per share for the six months ended in Dec. 2024 was HK$0.15. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.26.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of PuraPharm was 30.20% per year.

During the past 11 years, PuraPharm's highest 3-Year average Operating Cash Flow per Share Growth Rate was -14.50% per year. The lowest was -23.60% per year. And the median was -19.05% per year.

PuraPharm Price-to-Operating-Cash-Flow Historical Data

The historical data trend for PuraPharm's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PuraPharm Price-to-Operating-Cash-Flow Chart

PuraPharm Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

2.11

5.71

4.46

2.09

PuraPharm Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															5.71	-	4.46	-	2.09

Competitive Comparison of PuraPharm's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, PuraPharm's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PuraPharm's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PuraPharm's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where PuraPharm's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

PuraPharm Price-to-Operating-Cash-Flow Calculation

PuraPharm's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.475	/	0.263
	=	1.81

PuraPharm's Share Price of today is HK$0.475.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PuraPharm's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.26.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

PuraPharm Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of PuraPharm's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

PuraPharm Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PuraPharm Corporation Ltd (HKSE:01498) » Definitions » Price-to-Operating-Cash-Flow

Traded in Other Exchanges

N/A

Address

Wireless Centre, Phase One, Unit 201-207, 2nd Floor, Hong Kong Science Park, Tai Po, New Territories, Hong Kong, HKG

Website

https://www.purapharm.com

PuraPharm Corporation Ltd is a Hong Kong-based Chinese medicine Company. It is engaged in the research and development, production, marketing, and sale of concentrated Chinese medicine granules (CCMG) products marketed under the brand Nong's. The organization provides Chinese medical diagnostic services and operates through several segments: China CCMG, Hong Kong CCMG, Chinese healthcare products, Plantation, and Clinics. The majority of its revenue comes from the Hong Kong CCMG segment, which mainly involves the sale of CCMG products, excluding sales through self-operated clinics in Hong Kong. The group derives revenue from customers located in Hong Kong, Mainland China, and Other countries.

Executives

Chan Yu Ling, Abraham	2101 Beneficial owner
Man Yee Wai, Viola	2202 Interest of your spouse
Fullgold Development Limited	2101 Beneficial owner

PuraPharm Headlines

No Headlines